Back to all case studies
Dental TechUSA & EuropeB2B ABMRevenue Growth
Dental Technology (AI)USA & EuropeB2B Marketing

How ToothLens.ai Dominated US & European Dental Markets, Securing 50+ Clients in 6 Months

AI-driven B2B marketing connected ToothLens.ai to major US hospital chains and dental networks — 50+ new clients and 70% revenue growth in 6 months.

How ToothLens.ai Dominated US & European Dental Markets, Securing 50+ Clients in 6 Months
50+
New Clients Secured
70%
Revenue Growth

Verified Outcomes

50+
New Clients Secured
70%
Revenue Growth
$50K
ARR Added (6 Months)
40%
More Qualified Leads

The Brief

Engagement summary at a glance.

Client
ToothLens.ai (dental AI startup · USA + Europe expansion)
Engagement
6-month ABM-led growth engagement
Industry
Dental Technology (AI)
Scope
  • ICP definition for DSO + clinical-director buyers
  • Account-based marketing across US + Europe
  • Multi-touch outbound (email + LinkedIn + content)
  • Dental-tech-specific positioning + collateral
  • Pipeline + revenue dashboard
01

The Context

What was happening before we stepped in.

ToothLens.ai possessed cutting-edge dental AI technology but lacked meaningful market penetration in the hyper-competitive US and European dental sectors. They needed to transition from an innovative startup to a recognized industry leader — in less than six months. Generic marketing campaigns were generating zero traction with DSO executives and clinical procurement teams.

02

The Problem

The friction we identified and eliminated.

The dental market is trust-based and relationship-driven. Decision-makers at Dental Service Organizations (DSOs) and hospital chains don't respond to cold outreach that feels impersonal or generic. Without industry-specific targeting and localized messaging, even the best dental AI product remains invisible.

Our Solution

The strategic and technical intervention.

We designed AI-driven Account-Based Marketing (ABM) campaigns targeting clinical directors and DSO executives across the US and Europe. Rather than broadcasting to broad audiences, we identified the highest-value accounts with active technology purchasing cycles and delivered hyper-relevant, compliance-aware content that spoke directly to their clinical and operational challenges.

Implementation Summary

Ran AI-driven B2B ABM campaigns targeting dental market decision-makers in the US and Europe, focusing on revenue generation over brand awareness.

Our Approach

The phased methodology, in order.

  1. 01

    Reframed positioning around DSO procurement language

    ToothLens had been pitched in the language of clinical AI — accuracy, sensitivity, specificity. The DSO buyers we needed to reach speak a different language: chairs, ops cost, recall rates, hygienist productivity. We rewrote the entire narrative around the operational and financial impact of dental AI in a multi-clinic environment, without dumbing down the clinical credibility.

  2. 02

    Built a true account-based target list

    Mass outreach was already failing. We pivoted to a tightly defined list: the top 200 DSOs in the US, the largest hospital-affiliated dental groups in Europe, and the most progressive single-location practices that act as early adopters. Every account had an identified executive sponsor and a clinical champion before the first message went out.

  3. 03

    Multi-touch sequences with clinical credibility built in

    Every outreach touch carried a piece of clinical evidence — a peer-reviewed study, an x-ray comparison, a real DSO case — not a generic pitch. We mixed email, LinkedIn, and high-quality content (positioning ToothLens as the thought leader, not just a vendor). Reply rates from clinical directors more than doubled compared to the prior generic motion.

  4. 04

    Layered in a thought-leadership content engine

    We shipped a tight cadence of long-form content — DSO economics of dental AI, accuracy benchmarks against incumbents, change-management playbooks for clinical adoption — and amplified it through targeted LinkedIn ads to the named account list. The content opened doors before any cold message ever did.

  5. 05

    Dialled in the sales handoff with full clinical context

    Every booked meeting landed in HubSpot with the prospect's clinic profile, the specific clinical evidence they'd engaged with, and a one-page brief. Sales walked into demos already knowing what mattered to that DSO — close rates on engine-sourced meetings ran materially higher than on inbound MQLs.

What We Built

The artefacts shipped during the engagement.

DSO-positioned narrative + collateral

Rewrote the full GTM narrative for DSO procurement and clinical-director audiences, including web pages, one-pagers, and demo scripts.

Named-account target list (US + EU)

200 DSOs + large dental groups + early-adopter practices, fully enriched with executive sponsor, clinical champion, and decision-cycle hypothesis per account.

Multi-touch ABM sequences

Email + LinkedIn + content sequences carrying clinical evidence at every touch, segmented by buyer role.

Content + LinkedIn ad engine

DSO-focused thought-leadership content amplified through targeted LinkedIn ads against the named account list.

Pipeline + revenue dashboard

Single-pane view tracking accounts, conversation stage, pipeline value, and revenue contribution.

Measurable Outcomes

50+
New Clients Secured

50+ new dental clients onboarded across the US and Europe within six months — a mix of DSO multi-location deployments and progressive single-location adopters who became reference accounts for the next wave.

70%
Revenue Growth

70% revenue growth across the engagement period, driven by higher-ticket DSO contracts (compared to the prior single-clinic deal mix) and stronger expansion within onboarded accounts.

$50K
ARR Added (6 Months)

$50K of net-new ARR added inside six months — entirely attributable to the ABM engine. The pipeline mix tilted from low-ticket single-clinic deals to multi-location DSO deals, lifting average contract value.

40%
More Qualified Leads

Qualified-lead volume grew 40% even as we tightened the ICP and stopped working low-fit accounts. The number went up because every account in the new pipeline was actually closeable — not a noisy mix of dreamers and tyre-kickers.

The Stack

Apollo.ioClaySmartleadLinkedIn Sales NavigatorLinkedIn AdsGPT-4oWebflowHubSpotSlack

Project Timeline

  1. Mo 01

    Narrative + ICP rebuild

    Repositioned for DSO procurement language; named-account list locked.

  2. Mo 02

    Sequence + content build

    Multi-touch ABM sequences live; first long-form thought-leadership pieces published.

  3. Mo 03

    Launch + first wins

    Engine live across US + EU named-accounts; first clinical-director meetings booked; early DSO pilots closed.

  4. Mo 04

    Scale

    LinkedIn ad amplification layered in; pipeline crossed key threshold; first multi-location DSO deals signed.

  5. Mo 05

    Optimisation

    Tuned sequences against won/lost data; ICP refined; close rate on engine-sourced meetings stabilised meaningfully above inbound.

  6. Mo 06

    Steady-state

    50+ new clients onboarded, $50K ARR added, predictable monthly pipeline contribution from the engine.

We had the technology. What we didn't have was a way to talk to DSO buyers in their language and reach them at scale. Six months in, our pipeline mix completely flipped — multi-location DSO deals are now the norm, not the exception.
Founder·ToothLens.ai

Key Takeaway

Global market domination requires moving past 'buzz' and focusing on revenue-driven GTM. AI enables the hyper-targeting precision necessary to secure enterprise-level dental clients at scale.

Frequently asked, about this engagement.

Why did broad digital marketing fail for ToothLens before?

The dental market — especially DSOs — is small, trust-based, and vendor-skeptical. Broad campaigns generate noise; serious DSO procurement teams ignore noise. The only motion that works is named-account ABM with clinical credibility built into every touch, which is what we ran.

How do you build clinical credibility in cold outreach?

Every outreach touch carried a piece of real clinical evidence — peer-reviewed accuracy benchmarks, anonymised x-ray comparisons, DSO case examples. We never led with marketing language; we led with the evidence the clinical director needed to take the next call seriously.

Does this approach work in markets outside the US and EU?

Yes, with localisation. We've adapted the same DSO-procurement-language playbook for Indian dental chains, Middle Eastern dental groups, and Australian DSOs. The buyer language shifts, the underlying procurement psychology doesn't.

How long before a similar engagement starts producing ARR?

First booked DSO meetings in 2–4 weeks. First closed multi-location deals in months 2–3. Predictable monthly ARR contribution from the engine by month 4. The ToothLens timeline mirrored this almost exactly.

Related solutions

Want results like ToothLens.ai?

Book a strategy call. We'll map exactly what to build, what to skip, and what it should cost for your business.

Next case studyNew Port Homes Dubai